Protracted high-dose interferon gamma therapy for chronic experimental nephropathy
- 31 December 1994
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 54 (4) , PL45-PL50
- https://doi.org/10.1016/0024-3205(94)00820-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Modified plasma clearance technique using nonradioactive iothalamate for measuring GFRKidney International, 1992
- Tubulointerstitial Changes as a Major Determinant in the Progression of Renal DamageAmerican Journal of Kidney Diseases, 1992
- Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosisKidney International, 1991
- Transforming-growth-factor-β activation elements in the distal promoter regions of the rat α1 type I collagen geneBiochemical Journal, 1991
- Transforming Growth Factors β1 and α in Chronic Liver DiseaseNew England Journal of Medicine, 1991
- Tumor necrosis factor-alpha and interferon-gamma suppress the activation of human type I collagen gene expression by transforming growth factor-beta 1. Evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional levels.Journal of Clinical Investigation, 1990
- Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1Nature, 1990
- Adriamycin-induced nephropathy as a model of chronic progressive glomerular diseaseKidney International, 1986
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- Simple and micro high-performance liquid chromatographic method for simultaneous determination of p-aminohippuric acid and iothalamate in biological fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1984